Earnings are out
Neuphoria Therapeutics (NEUP)
Develops BNC210 for anxiety and trauma-related disorders through virtualized clinical development.
$3.75
At close−0.04 (−1.06%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions19 holders · as of Mar 31, 2026 | 32.53% | 1.76M shares | |
| Otherremainder | 67.47% | 3.65M shares |
5.40M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
19 holders · 1.76M shares · 6 new positions · 11 increased · 1 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| LYNX1 Capital Management LP | 875.3K | 16.20% | +100 | May 4, 2026 |
| Advisorshares Investments LLC | 155.4K | 2.87% | +21.2K | Apr 28, 2026 |
| Shay Capital LLC | 151.0K | 2.79% | −18.0K | May 15, 2026 |
| Balyasny Asset Management L.P. | 142.2K | 2.63% | +142.2Knew | May 15, 2026 |
| Vanguard Capital Management LLC | 98.5K | 1.82% | +98.5Knew | May 15, 2026 |
| Squadron Capital Management LLC | 76.7K | 1.42% | +76.7Knew | May 15, 2026 |
| Geode Capital Management, LLC | 52.0K | 0.96% | +34.7K | May 15, 2026 |
| Ikarian Capital, LLC | 47.4K | 0.88% | 0 | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Lynx1 Capital Management LPincl. Weston Nichols | 16.30% | 875.3K | 13D | Dec 29, 2025 ↗ |
| Armistice Capital, LLCincl. Steven Boyd | 9.99% | Nov 14, 2024 ↗ | ||
| Shay Capital LLC | 7.30% | 171.6K | 13G | Oct 31, 2025 ↗ |
| Coastlands Capital LP | 5.10% | 120.0K | 13G | Nov 5, 2025 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Oct 21, 2025 | Lynx1 Capital Management LP10 percent owner | Purchase | 639,110 | $5.14 | 875,328 |
CongressHouse and Senate disclosures
Not reported.
